Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.730
-0.040 (-2.26%)
At close: Jul 11, 2025, 4:00 PM
1.810
+0.080 (4.61%)
After-hours: Jul 11, 2025, 5:55 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $51.13 million as of July 11, 2025. Its market cap has increased by 56.28% in one year.
Market Cap
51.13M
Enterprise Value
42.67M
1-Year Change
56.28%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $51.13M, a decrease of -58.97%. That is a compound annual growth rate of -18.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 51.13M | -10.75% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |